Home › Multiple Myeloma › New York › New Rochelle
Multiple Myeloma clinical trials in New Rochelle, NY
14 studies for Multiple Myeloma are looking for participants at sites in and around New Rochelle (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Study of IgPro20 to Prevent Infection in People With Multiple Myeloma and Hypogammaglobulinemia
RecruitingPhase 2
- Memorial Sloan Kettering Westchester (All Protocol Activities), Harrison · 5 mi away
A Study of a Plant-Based Diet and Dietary Supplements in People With Smoldering Multiple Myeloma (SMM) or Monoclonal Gammopathy of Undetermined Significance (MGUS)
Recruiting
- Memorial Sloan Kettering Westchester (All Protocol Activities), Harrison · 5 mi away
A Study of Melphalan With or Without Siltuximab in People With Multiple Myeloma Having an Autologous Stem Cell Transplant
RecruitingPhase 2
- Memorial Sloan Kettering Westchester (Limited Protocol Activities), Harrison · 5 mi away
A Study to Learn About the Effects of the Combination of Elranatamab, Daratumumab and Lenalidomide Compared With Daratumumab, Bortezomib, Lenalidomide, and Dexamethasone in Patients With Newly Diagnosed Multiple Myeloma Who Are Not Candidates for Transplant
RecruitingPhase 3
- MSK Westchester, Harrison · 5 mi away
A Study to Learn About the Study Medicine Elranatamab Alone and With Daratumumab in People With Multiple Myeloma Who Have Received Other Treatments
RecruitingPhase 3
- MSK Westchester, Harrison · 5 mi away
MagnetisMM-32: A Study to Learn About the Study Medicine Called Elranatamab in People With Multiple Myeloma (MM) That Has Come Back After Taking Other Treatments (Including Prior Treatment With an Anti-CD38 Antibody and Lenalidomide)
RecruitingPhase 3
- North Shore University Hospital, Manhasset · 9 mi away
A Study of Teclistamab and Mezigdomide in People With Multiple Myeloma
RecruitingPhase 1
- Memorial Sloan Kettering Westchester (Limited Protocol Activities), Harrison · 5 mi away
A Study of Voice as a Way to Monitor for Side Effects in People Receiving CAR T-Cell Therapy
RecruitingObservational study
- Memorial Sloan Kettering Westchester (Consent only), Harrison · 5 mi away
A Study of Dara-RVd and Teclistamab-RVd in People With Multiple Myeloma
RecruitingPhase 1/2
- Memorial Sloan Kettering Westchester (Limited Protocol Activities), Harrison · 5 mi away
A Study of CyBorD (Cyclophosphamide, Bortezomib, Dexamethasone) Plus Daratumumab in People With Monoclonal Gammopathy of Renal Significance (MGRS)
RecruitingPhase 2
- Memorial Sloan Kettering Westchester (Limited Protocol Activities), Harrison · 5 mi away
A Study of Elranatamab and Cyclophosphamide in People With Multiple Myeloma
RecruitingPhase 2
- Memorial Sloan Kettering Westchester (All Protocol Activities), Harrison · 5 mi away
A Dietary Study for People With Multiple Myeloma
Recruiting
- Memorial Sloan Kettering Westchester (Limited Protocol Activities), Harrison · 5 mi away
A Study of Talquetamab for People With Multiple Myeloma Who Have Received BCMA CAR T-Cell Therapy
RecruitingPhase 2
- Memorial Sloan Kettering Westchester (Limited Protocol Activities), Harrison · 5 mi away
Ascertainment of Families for Genetic Studies of Familial Lymphoproliferative Disorders
RecruitingObservational studyHealthy volunteers welcome
- Memorial Sloan Kettering Westchester, Harrison · 5 mi away
About Multiple Myeloma
Multiple myeloma is a cancer that begins in plasma cells, a type of white blood cell. Discover symptoms, diagnostic tests, and treatments for myeloma.
More about Multiple Myeloma on MedlinePlus
Multiple Myeloma trials in other cities
- New York City, NY60 studies
- Atlanta, GA42 studies
- Boston, MA42 studies
- Houston, TX38 studies
- Durham, NC37 studies
- Nashville, TN32 studies
- Denver, CO27 studies
- Rochester, MN24 studies
- St. Louis, MO24 studies
- Columbus, OH24 studies
- Baldwin Park, CA23 studies
- Chicago, IL22 studies
Other studies in New Rochelle
- Breast Cancer38 studies
- Non-Small Cell Lung Cancer18 studies
- Prostate Cancer16 studies
- Acute Myeloid Leukemia13 studies
- Bladder Cancer11 studies
- Lung Cancer11 studies
- Endometrial Cancer11 studies
- Metastatic Cancer10 studies
- Cancer (all types)10 studies
- Ovarian Cancer9 studies
- Cardiovascular Disease8 studies
- Pancreatic Cancer8 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.